Friday, 16 October 2026European Markets

NEXITY And WERELDHAVE BELGIUM Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - nexity (nxi.pa) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
nexity (nxi.pa) €24.48 10.26% 10.25%
wereldhave belgium (wehb.br) €55.40 7.69% 8.05%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. nexity (nxi.pa)

10.26% forward dividend yield and 10.25% return on equity

nexity sa operates as a real estate company in europe and internationally. the company operates through development, services, and other activities divisions. it develops new homes and subdivisions; and new or refurbished office buildings, high-rises, business parks, logistics facilities, retail property, hotels, and other industrial spaces. the company also provides property management services comprising rental management, sales and lettings, and condominium managing agent services, as well as manages serviced residences for students and for seniors; distributes real estate products under the iselection and perl brands; offers real estate brokerage, and space planning services; and real estate services, including rental management and property management services. in addition, it engages in the villes and projets, and pre-development urban regeneration project activities; and investment activities, as well as startup in the incubation phase. the company serves individual, commercial, institutional, and local authority clients. nexity sa was founded in 1995 and is headquartered in paris, france.

earnings per share

as for profitability, nexity has a trailing twelve months eps of €2.99.

pe ratio

nexity has a trailing twelve months price to earnings ratio of 8.19. meaning, the purchaser of the share is investing €8.19 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.25%.

dividend yield

according to morningstar, inc., the next dividend payment is on may 24, 2023, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 10.26%.

volume

today's last reported volume for nexity is 81245 which is 36.92% below its average volume of 128808.

sales growth

nexity's sales growth for the current quarter is negative 3.9%.

more news about nexity.

2. wereldhave belgium (wehb.br)

7.69% forward dividend yield and 8.05% return on equity

wereldhave belgium focuses on shopping centres and retail parks that are dominant in their catchment area. the shares are listed on the euronext brussels stock exchange. on 31 march 2020, wereldhave belgium's market capitalisation amounts to € 403 million.

earnings per share

as for profitability, wereldhave belgium has a trailing twelve months eps of €6.24.

pe ratio

wereldhave belgium has a trailing twelve months price to earnings ratio of 8.88. meaning, the purchaser of the share is investing €8.88 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.05%.

volatility

wereldhave belgium's last week, last month's, and last quarter's current intraday variation average was a positive 0.62%, a negative 0.21%, and a positive 1.14%.

wereldhave belgium's highest amplitude of average volatility was 2.33% (last week), 1.25% (last month), and 1.14% (last quarter).

volume

today's last reported volume for wereldhave belgium is 2890 which is 78.17% above its average volume of 1622.

revenue growth

year-on-year quarterly revenue growth grew by 4.2%, now sitting on 60.23m for the twelve trailing months.

more news about wereldhave belgium.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com